Cordlife Group Limited's latest marketcap:
As of 06/12/2025, Cordlife Group Limited's market capitalization has reached $57.1 M. According to our data, Cordlife Group Limited is the 28515th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 57.1 M |
| Revenue (ttm) | 21.61 M |
| Net Income (ttm) | -14,760,841.1 |
| Shares Out | 256.31 M |
| EPS (ttm) | -0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2025 |
Cordlife Group Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/12/2025 | S$57.1 M | 86.67% | 28515 |
| 12/30/2024 | S$38.45 M | -52.38% | 31881 |
| 12/29/2023 | S$80.74 M | -1.44% | 26413 |
| 12/30/2022 | S$81.91 M | -19.79% | 25525 |
| 12/30/2021 | S$102.12 M | 0.28% | 24947 |
| 12/31/2020 | S$101.83 M | 22149 |
Company Profile
Cordlife Group Limited Overview
Cordlife Group Limited is an investment holding company specializing in cord blood banking and diagnostic services. Headquartered in Singapore, the company operates across multiple regions, including Hong Kong, India, Malaysia, the Philippines, and internationally.
Business Segments
- Banking Segment: Collects, processes, banks, and tests biological materials such as cord blood, lining, and tissue samples.
- Diagnostics Segment: Provides newborn genetic and metabolic screenings, pediatric vision and ear screenings, allergen tests, and genetic talent tests.
Additional Services
- Corneal lenticule banking and gut microbiome banking.
- Lifestyle genetic screening services for adults.
- Moms Up: A mobile application offering parenting resources and health & wellness solutions.
- Medical laboratory, marketing, and property investment services.
- Medical and pharmaceutical R&D, along with consulting services.
Company Background
Founded in 2001, Cordlife Group Limited is based in Singapore and has established itself as a leader in cord blood banking and diagnostic solutions.
Frequently Asked Questions
-
What is Cordlife Group Limited's (SGX-P8A) current market cap?As of 06/12/2025, Cordlife Group Limited (including the parent company, if applicable) has an estimated market capitalization of $57.1 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cordlife Group Limited (SGX-P8A) rank globally by market cap?Cordlife Group Limited global market capitalization ranking is approximately 28515 as of 06/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.